ArticleLeukemia research2015

Synergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL⁺ leukemia cells.

Tri Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.